Prevalence of children born small for gestational age with short stature who qualify for growth hormone treatment

• Main Authors: Gianluca Tamaro (Author), Mariagrazia Pizzul (Author), Giuliana Gaeta (Author), Raffaella Servello (Author), Marina Trevisan (Author), Patricia Böhm (Author), Paola Manera Ada Materassi (Author), Anna Macaluso (Author), Denis Valentini (Author), Maria Chiara Pellegrin (Author), Egidio Barbi (Author), Gianluca Tornese (Author)
• Format: Book
• Published: BMC, 2021-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Recombinant human growth hormone (rhGH) is approved in Europe as a treatment for short children born small for gestational age (SGA) since 2003. However, no study evaluated the prevalence of SGA children with short stature who qualify for rhGH in Europe so far. This study aimed t...